Thrombolytic therapy or surgery for valve prosthesis thrombosis: systematic review and meta-analysis.

Link to article at PubMed

Thrombolytic therapy or surgery for valve prosthesis thrombosis: systematic review and meta-analysis.

J Thromb Haemost. 2014 Apr 2;

Authors: Castilho FM, Sousa MR, Mendonça AL, Ribeiro AL, Cáceres-Lóriga FM

BACKGROUND: Prosthetic heart valve thrombosis is a life-threatening condition for which treatment has not been evaluated by randomized trials.
OBJECTIVES: To compare surgery with thrombolytic therapy for the treatment of prosthetic valve thrombosis.
METHODS: A comprehensive systematic review was carried out by independent researchers in PubMed, Web of Knowledge, HINARI, LILACS and EMBASE; including papers indexed up to October 23th 2013 with at least 10 patients, evaluating one or both treatment options. Outcomes of interest were death, stroke, bleeding, embolic events and success. Study quality was assessed by Newcastle-Ottawa Scale (ranges from 0 to 9). Comprehensive Meta Analysis Software was used to pool study results, for publication bias analysis and for meta-regression.
RESULTS: Forty eight studies were included (2302 patients). No randomised study was identified, and all were observational in design. Study quality varied from 4 to 6 stars using the Newcastle-Ottawa Scale. Mortality for surgery was 18.1% (95%CI 14.6-22.1; I(2) 62% [42-75]), while mortality for thrombolytic therapy was 6.6% (95% CI 4.8-8.9; I(2) 0% [0-13]). Surgical mortality appeared to increase with NYHA-class, according to meta-regression. Other results related to surgery and thrombolytic therapy, respectively, were: embolic events 4.6%(2.9-7.3) and 12.8%(10.8-15.2); stroke 4.3%(2.7-6.6%) and 5.6%(4.3-7.4%); success rate 81.9%(77.2-85.8) and 80.7%(75.6-85.0); bleeding 4.6%(2.9-7.1) and 6.8%(5.4-8.6); death or stroke 19.0%(14.8-24.2) and 11.4%(8.7-14.7).
CONCLUSION: Mortality in patients treated by thrombolytic therapy for valve prosthesis thrombosis is significantly lower than in patients treated surgically. As we cannot yet ascertain whether this difference is due to the treatment alone, more studies now are necessary to further clarify these findings. This article is protected by copyright. All rights reserved.

PMID: 24698327 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.